&Partners’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
&Partners's ACLS Position: Q2 2026 in Review
&Partners reduced its Axcelis (ACLS) stake by 25% in Q2 2026, selling an estimated $514K and leaving 10,621 shares worth $2.01M. The position accounts for 0.01% of the portfolio, ranked #1028.
&Partners first reported a position in ACLS in Q1 2023 and has held it in 11 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- &Partners held 10,621 shares of Axcelis worth $2.01M as of Q2 2026.
- &Partners sold 3,466 Axcelis shares in Q2 2026, an estimated $514K.
- Axcelis made up 0.01% of &Partners's portfolio in Q2 2026, its #1028 holding.
- &Partners first reported a position in Axcelis in Q1 2023 and has held it in 11 quarters since.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.